Structured evidence table for Sesame Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Sesame Blood Pressure Randomized Trial | It is often associated with hormonal imbalance, metabolic disturbances, and reproductive complications, which together contribute to an elevated risk of long-term cardiometabolic disorders. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Sesame Blood Pressure Randomized Trial | To narratively synthesize mechanistic rationale and human clinical evidence on dietary seeds and selected nutraceuticals relevant to PCOS, with emphasis on metabolic and reproductive endpoints of interest to nutrition and obstetrics/gynecology practice. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Sesame Blood Pressure Randomized Trial | Proposed "seed cycling" protocols have received attention, yet most clinical data are derived from mixed-seed supplementation studies or low-level evidence, such as case reports, and should be considered hypothesis-generating. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Sesame Blood Pressure Randomized Trial | Polycystic ovary syndrome (PCOS) represents one of the most common endocrine disorders among women of reproductive age. | 4 | Singnale P (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. |
| Sesame Blood Pressure Randomized Trial | ) supplementation may offer beneficial effects in modulating various cardiometabolic risk factors, although findings from clinical trials have been inconsistent. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Sesame Blood Pressure Randomized Trial | Sesame supplementation significantly reduced both systolic and diastolic blood pressure. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Sesame Blood Pressure Randomized Trial | Further-more, sesame intake was associated with a significant reduction in liver enzyme levels, particularly alanine aminotransferase (ALT). | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Sesame Blood Pressure Randomized Trial | Background Cardiometabolic disorders, such as diabetes, hypertension, dyslipidemia, retinopathy, and non-alcoholic fatty liver disease, present significant health challenges globally. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
Source documents